What Is BPC-157 Peptide? Body-protective compound 157 (BPC157) is a stable gastric pentadecapeptide extensively studied in experimental rat models for its biological effects under controlled conditions. It is not an approved therapeutic in humans, but preclinical research shows diverse influences on tissue healing, neurological biochemistry, and systemic pharmacokinetics in rodents.
BPC-157 Peptide in Wound Healing and Tissue Repair Research In wound healing and tissue repair paradigms, BPC157 has been shown to enhance granulation, angiogenesis, and collagen deposition in rats. In models including skin incisional wounds, colon-colon anastomoses, and implanted synthetic sponges, rats treated with BPC157 exhibited significantly better healing outcomes compared with controls across different administration routes (e.g., intragastric and local application). This suggests robust promotion of connective tissue repair and vascularization in injured tissues. (PubMed)
BPC-157 5mg to 20mg: Pharmacokinetics in Rat Models Pharmacokinetic studies in rats reveal rapid systemic distribution after intramuscular administration, with a relatively short elimination half-life (< 30 min) and primary excretion via urine and bile. BPC157 is metabolized into smaller peptide fragments, eventually entering normal amino acid metabolism pathways. These profiles help define exposure and clearance in rodent models, which are crucial for interpreting dose–response and safety in experimental conditions. (PubMed)
BPC-157 Peptide and Neurological Pathway Research Beyond wound repair, BPC157 affects neurological and biochemical pathways in rat studies. For example, acute and repeated dosing altered regional serotonin synthesis in rat brains, with significant modulatory effects on areas such as the hippocampus and hypothalamus, indicating central nervous system influences extending beyond peripheral tissue healing. (PubMed)
BPC-157 for Sale: Research Summary and Safety Profile
Overall, experimental use of BPC157 in rats spans multiple systems, consistently demonstrating pro-healing and modulatory actions under controlled experimental conditions. These findings form the basis for ongoing interest in translational research, although clinical validation in humans remains limited.
Buy BPC-157 from NuScience Peptides to support your tissue repair and cytoprotection research. For synergistic studies, explore the BPC-157/TB-500 Blend and the GLOW Blend (GHK-Cu, BPC-157, TB-500). BPC-157 is also available in oral BPC-157 Capsule format. Use our Peptide Calculator to determine reconstitution volumes.
References (APA): He, F., Guo, Z., Zhou, L., Li, X., Zhang, L., Zhang, Z., ... & Li, L. (2022). Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. PubMed. (PubMed)
Sikiric, P., Seiwerth, S., Grabarevic, Z., Petek, M., Rucman, R., Turkovic, B., ... & Rotkvić, I. (1997). BPC 157’s effect on healing: Organoprotective actions in experimental rat models. Journal of Physiology-Paris. (PubMed)
Tao, R., & Li, J. (2004). Effects of pentadecapeptide BPC157 on regional serotonin synthesis in the rat brain: Alpha-methyl-L-tryptophan autoradiographic measurements. PubMed. (PubMed)